For a youthful, firmer you, ask for Sculptra®
Sculptra® activates the power of your skin by revitalizing collagen production.¹ With Sculptra®, you will renew skin thickness and firmness and correct shallow to deep wrinkles and folds.² Sculptra® gradually builds the foundations of the youthful, firmer you, day after day.³
Why Sculptra®?
Sculptra® activates the skin’s ability to produce collagen, restoring the skin’s structure and renewing its natural firmness.4 Collagen is a fibrous protein in the deeper layers of your skin and is key in making your skin look young and healthy. As you age, your body’s collagen production decreases. The loss of collagen will in time lead to loose and saggy skin and the formation of facial wrinkles and folds.5
Sculptra® is the original collagen stimulator that will renew your skin in a gradual and long-lasting way by stimulating collagen production.6 Sculptra® gives you control of your skin and the power to look as great as you feel.
TREATMENT AREAS
Sculptra® volume and firmness to areas of your face that have become loose and saggy.7 Examples include smile lines (also called nasolabial folds), laugh lines (or marionette lines) and chin wrinkles. The treatment helps gradually replace lost collagen and results may last for more than two years.8 Sculptra®will reinvigorate your skin and bring back your youthful appearance.
80% of users were still satisfied with their Sculptra® treatment 25 months after their last injection, according to a clinical study.9
Your Sculptra® treatment
Sculptra® is injected in the deep layers of your skin to stimulate its own collagen production.10 You will gradually notice visible improvements of skin firmness and fullness, and results can last for more than two years.11 On average, three treatment sessions are needed over a few months.
Immediately after each treatment session, you may experience some swelling that will temporarily reduce wrinkles and folds. Thereafter, the gradual process of collagen replacement starts. Sculptra® works subtly, improving facial areas gradually to give you a youthful and natural-looking result that lasts.
How it works
The active ingredient in Sculptra® is poly-L-Lactic acid, PLLA. PLLA is a biodegradable substance that has been used for decades in dissolvable stitches for wound management. When PLLA is injected in the deeper layers of your skin, it helps stimulate your skin’s own natural collagen production.12 Thereby, your skin’s inner structure is improved and you will regain skin volume that has been lost to aging.13
80% rated Sculptra® as good to excellent after 25 months14
100% of patients would recommend Sculptra® to a friend15
Proven aesthetic results since 199916
FREQUENTLY ASKED QUESTIONS
Will the treatment be painful?
As with any injection, some pain at the treatment site is possible, but your healthcare practitioner may use a topical anesthetic to ease any discomfort.
How soon will I see results?
Sculptra is designed to give you noticeable results that emerge gradually with increased collagen production. Don’t be disappointed if you don’t see immediate results. A few days after treatment, you may look as you did before treatment. This is normal and temporary. The Sculptra regimen delivers its full effects with an average of three treatment sessions over the course of a few months. Because results happen gradually, you will see subtle, yet noticeable, results in the reduction of facial wrinkles and folds by comparing images before treatment and a couple months following treatment.*
*Safety and effectiveness of Sculptra have not been evaluated in areas other than nasolabial wrinkles and folds.
What should I apply or avoid after treatment?
In the days following your treatment, keep a few things in mind for swift healing and optimum results:
Cold pack: A cold pack or ice pack will help reduce any common swelling. Within the first 24 hours of treatment, apply a cloth-wrapped cold pack to the treated area for a few minutes at a time. Never apply ice directly to the skin.
Facial massage: Massage the treated area for five minutes five times a day for five days after treatment, as recommended by your healthcare practitioner.
Avoid sunlight: After treatment, excessive sunlight and UV lamp exposure should be avoided until any initial swelling and redness go away. Your healthcare practitioner will provide guidelines on sunscreen protection and how to avoid excessive sunlight.
How soon after treatment can I wear makeup?
If there are no complications, you may apply makeup several hours after treatment. Be sure to consult your healthcare practitioner after treatment.
Is Sculptra safe? What are the side effects?
Sculptra was CE approved for aesthetic use in the European market in 1999 and is FDA approved in the United States. Sculptra is made of a synthetic material called poly-L-lactic acid that is absorbed naturally by the body and has been used for years in dissolvable stitches. Since Sculptra does not contain any human or animal components, no allergy testing is needed prior to treatments.
Common side effects reported include pain at the treatment area, redness, bruising, tenderness, itching and lumps, bleeding or swelling. Small bumps under the skin can sometimes be noticeable when pressing on the treated area. Larger lumps, with or without inflammation, have also been reported. Common side effects usually resolve spontaneously within 2 to 7 days. If you are experiencing side effects, talk to your healthcare practitioner.
Who should not have a treatment with Sculptra?
Sculptra is indicated for use in people with healthy immune systems as a single regimen for the correction of shallow to deep nasolabial folds and other facial wrinkles by stimulating collagen production. You should not receive treatment if you have an active skin infection or skin inflammation near the planned injection site.
Sculptra should not be used by people that are allergic to any ingredient of the product or have a history of keloid formation or hypertrophic scarring. Safety has not been established in patients who are pregnant, lactating, breastfeeding or under 18 years of age.
Are you looking for a clinic?
Skin insights
OUR PORTFOLIO OF PRODUCTS
Galderma has developed a diverse portfolio of products that work holistically together.
REFERENCES
1 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
2 Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.
3 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg
2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.;
Moyle GJ et al. HIV Med 2004;5(2):82–7.; Bohnert K et al. Plast Reconstr Surg
2019;127(4):1684–92
4 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
5 Fisher GJ et al. Arch Dermatol 2008;144(5):666–72.; Werschler WP et al. J Clin Aesthet Dermatol 2015;8(10 Suppl):S2–S7.
6 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
7 Stein P et al. J Dermatol Sci 2015;78(1):26–33.9.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Vleggaar D et al. J Drugs Dermatol 2014;13(4 suppl):s29–31.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
8 Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.
9 Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
10 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
11 Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
12 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.
13 Stein P et al. J Dermatol Sci 2015;78(1):26–33.; Goldberg D et al. Dermatol Surg 2013;39(6):915–22.; Moyle GJ et al. HIV Med 2004;5(2):82–7.; Nelson L and Stewart KJ. J Plast Reconstr Aesthet Surg 2012;65(4):439–47.; Mest DR and Humble G. Dermatol Surg 2006;32(11): 1336–45.; Valantin MA et al. AIDS 2003;17(17):2471–7.; Narins RS et al. J Am Acad Dermatol 2010;62(3):448–62.; Brandt FS et al. Aesthet Surg J 2011;31(5):521–8.; Chen HH et al. JAMA Facial Plast Surg 2015;17(1):39–43.
14 Brown SA et al. Plast Reconstr Surg 2011;127(4):1684–92.
15 Mest DR and Humble G. Dermatol Surg 2006;32(11):1336–45.
16 Sculptra was developed and CE approved for aesthetic use in the European market in 1999.